Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of vitamin D biological effects in resectable urinary tract urothelial carcinoma
2017-000695-28Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vitamin d in transitional cell carcinoma (TCC), transitional cell carcinoma of the bladder (TCC) and Bladder cancer in situ (CIS), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Tumor expression of differentiation and vitamin D response markers. Started May 2018; status: completed.
02
Drugs
vitamin d
03
Conditions
transitional cell carcinoma (TCC)transitional cell carcinoma of the bladder (TCC)Bladder cancer in situ (CIS)
Beyond the preview
Go deeper on 2017-000695-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000695-28.